Amyloid-beta-IN-1 (compound 13) is a synthetic peptide containing the hydrophobic C-terminal region VVIA-NH2 and its reverse sequence AIVV-NH2 of Abeta42, which is an Abeta inhibitor. Amyloid-beta-IN-1 can inhibit Abeta aggregation and has neuroprotective effects[1].
Molekulargewicht:
385.50
Formel:
C18H35N5O4
Target-Kategorie:
Amyloid-beta
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
